In recent months, six real estate industry sources told The Boston Globe, Vertex officials have toured a number of lab development sites in the Seaport, looking for a possible replacement for its 1.1 ...

No patients have received Casgevy, CRISPR Therapeutics and Vertex Pharmeceuticals’ recently approved sickle cell gene therapy ...

A pharmaceutical company has hosted more than 60 paid interns since opening its purpose-built lab in 2021, in an attempt to ...

which was later acquired by Vertex Pharmaceuticals for $950 million. Semma was named after Melton’s now grown-up children, aimed at moving a laboratory breakthrough into the real world.

Vertex Pharmaceuticals ... Being an ex vivo cell therapy in which patient's cells are harvested, engineered in a lab, and the reinfused back into the patient, the entire treatment process can ...

In the meantime current gene therapies remain expensive and challenging to scale up because each patient’s batch of cells has ...

The VERTEX 80 and the VERTEX 80v vacuum FT-IR spectrometers from Bruker are based on the actively aligned UltraScan ™ interferometer, which provides PEAK spectral resolution. The precise linear ...

HOUSTON (AP) — Vertex Energy Inc. VTNR) on Thursday reported a loss of $53.8 million in its second quarter. The Houston-based company said it had a loss of 58 cents per share. HOUSTON ...

Laboratory measurements in patient-derived ... technology and programmes from Semma are now part of the foundation for Vertex Cell and Genetic Therapies, together with those from Exonics ...

Illuminating the experience of people living with sickle cell could improve patients’ lives and enhance all of medicine ...

Vertex franchise poses a significant downside risk. That said, Royalty Pharma has solid execution capabilities and is diversifying earnings with new investments. The company raised its 2024 ...

These are the best Shark vacuums we've tried at home and in the lab, with picks starting under ... our favorite was the Shark Vertex DuoClean. This battery-powered vacuum excelled in our testing ...